Forecast Of The Day: 3M’s Healthcare Revenue

March 24th, 2022 by Trefis Team
+27.93%
Upside
94.28
Market
121
Trefis
MMM: 3M Company logo
MMM
3M Company

What?

3M’s (NYSE:MMM) healthcare revenue rose from $7.8 billion in 2020 to $8.5 billion in 2021. Trefis expects the metric to grow to over $9.5 billion by 2023.

Why?

Relevant Articles
  1. 3M Stock To Trade Higher Post Q1?
  2. What Led To A 40% Fall In 3M Stock Since 2019?
  3. 3M Stock To Trade Higher Post Q4?
  4. Here’s Why 3M Stock Is A Better Pick Over Its Sector Peer
  5. Is There A Better Pick Over 3M Stock?
  6. What’s Next For 3M Stock After A 12% Rise In A Month?

We expect growth to be driven by stronger demand for the company’s food safety, medical solutions, oral care solutions, separation, and purification products.

So What?

We think 3M stock is undervalued at current levels. We value MMM at $185 per share, 25% ahead of the current market price.

See Our Complete Analysis For 3M

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.

Returns Mar 2022
MTD [1]		 2022
YTD [1]		 2017-22
Total [2]
 MMM Return 0% -17% -17%
 S&P 500 Return 3% -5% 102%
 Trefis MS Portfolio Return 2% -9% 259%

[1] Month-to-date and year-to-date as of 3/24/2022
[2] Cumulative total returns since the end of 2016

Invest with Trefis Market Beating Portfolios

See all Trefis Price Estimates